Cisplatin superior to carboplatin in adjuvant radiochemotherapy for locally advanced cancers of the oropharynx and oral cavity

Strahlentherapie und Onkologie

Volumn 188, Issue 1, 2012, Pages 42-48

  Rades, D ^a   Ulbricht, T ^a   Hakim, S G ^a   Schild, S E ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b MAYO CLINIC   (United States)

Author keywords

Carboplatin; Cisplatin; Head and neck cancer; Radiochemotherapy; Treatment outcome

Indexed keywords

CARBOPLATIN; CISPLATIN;

ADJUVANT THERAPY; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD TOXICITY; CANCER CONTROL; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; CONTROLLED STUDY; FEMALE; FIBROSIS; HISTOLOGY; HUMAN; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MUCOSA INFLAMMATION; NAUSEA AND VOMITING; NECK FIBROSIS; NEPHROTOXICITY; OROPHARYNX CANCER; OVERALL SURVIVAL; PROGNOSIS; RETROSPECTIVE STUDY; SKIN TOXICITY; TOXICITY; TUMOR LOCALIZATION; XEROSTOMIA;

AGED; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES;

EID: 84856350692     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-0005-z     Document Type: Article

References (16)

1. Ang KK, Trotti A, Brown BW et al (2001) Randomized trial adressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 51:571-578
2. Bruner DW, Wasserman T (1995) The impact on quality of life by radiation late effects. Int J Radiat Oncol Biol Phys 31:1353-1355
3. Chitapanarux I, Lorvidhaya V, Kamnerdsupaphon P et al (2007) Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: randomized, non-inferiority, open trial. Eur J Cancer 43:1399-1406 (Pubitemid 46874069)
4. De Andres L, Brunet J, Lopez-Pousa A et al (1995) Randomized trial of neoadjuvant cisplatin and fluorouracil versus carboplatin and fluorouracil in patients with stage IV-M0 head and neck cancer. J Clin Oncol 13:1493-1500
5. Eder-Czembirek C, Erovic BM, Czembirek C et al (2010) Betulinic acid a radiosensitizer in head and neck squamous cell carcinoma cell lines. Strahlenther Onkol 186:143-148
6. Hinerman RW, Mendenhall WM, Morris CG et al (2004) Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience. Head Neck 26:984-994 (Pubitemid 39488127)
7. Homma A, Shirato H, Furuta Y et al (2004) Randomized phase II trial of concomitant chemoradiotherapy using weekly carboplatin or daily low-dose cisplatin for squamous cell carcinoma of the head and neck. Cancer J 10:326-332 (Pubitemid 44403471)
8. Jacob V, Bayer W, Astner ST et al (2010) A planning comparison of dynamic IMRT for different collimator leaf thicknesses with helical tomotherapy and RapidArc for prostate and head and neck tumors. Strahlenther Onkol 186:502-510
9. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
10. Lee WR, Berkey B, Marcial V et al (1998) Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: A secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys 42:1069-1075 (Pubitemid 29004150)
11. Mendenhall WM, Hinerman RW, Amdur RJ et al (2006) Postoperative radiotherapy for squamous cell carcinoma of the head and neck. Clin Med Res 4:200-208 (Pubitemid 44496013)
12. Stock M, Dörr W, Stromberger C et al (2010) Investigations on parotid gland recovery after IMRT in head and neck tumor patients. Strahlenther Onkol 186:665-671
13. Tribius S, Kronemann S, Kilic Y et al (2009) Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck. Strahlenther Onkol 185:675-681
14. Trotti A, Byhardt R, Stetz J et al (2000) Common toxicity criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 47:13-47 (Pubitemid 30179675)
15. Wong SJ, Harari PM, Garden AS et al (2011) Longitudinal oncology registry of head and neck carcinomas (LORHAN): analysis of chemoradiation treatment approaches in the United States. Cancer 117:1679-1686
16. Zwicker F, Hauswald H, Nill S et al (2010) New multileaf collimator with a leaf width of 5 mm improves plan quality compared to 10 mm in step-and-shoot IMRT of HNC using integrated boost procedure. Strahlenther Onkol 186:334-343